Revision by procedure characteristics

THA by type of revison
THA by procedure year
THA cemented by procedure year
THA uncemented by procedure year
THA anterior approach by procedure year
THA posterior approach by procedure year
THA by procedure side
THA by approach
THA by femoral head size
THA by articulation
THA by PE type
THA by modularity
THA by ODEP 5A or higher acetabulum
THA by ODEP 5A or higher femur
THA by cemented material acetabulum
THA by cemented material femur
THA by uncemented material femur
THA by uncemented material inlay

Hip » Survival » Revision by procedure characteristics » THA by type of revision

FIGURE Cumulative revision percentage of total hip arthroplasties by type of revision in the Netherlands in 2007-2022 (n=422,181)

TABLE Cumulative revision percentages

	Number at risk (n)	Competing Risk (95% CI)	Kaplan Meier¹ (95% CI)
Any type of revision
1-year revision (%)	376,573	1.6 (1.6-1.7)	1.6 (1.6-1.6)
3-year revision (%)	307,019	2.5 (2.5-2.6)	2.6 (2.5-2.6)
5-year revision (%)	234,419	3.1 (3.1-3.2)	3.2 (3.2-3.3)
10-year revision (%)	90,820	4.3 (4.3-4.4)	4.6 (4.6-4.7)
14-year revision (%)	17,037	5.3 (5.2-5.4)	6.0 (5.9-6.2)
Major revision²
1-year revision (%)	378,448	1.1 (1.1-1.1)	1.1 (1.0-1.1)
3-year revision (%)	308,894	1.9 (1.9-1.9)	1.9 (1.9-2.0)
5-year revision (%)	235,988	2.4 (2.4-2.5)	2.5 (2.4-2.6)
10-year revision (%)	91,574	3.6 (3.5-3.6)	3.8 (3.8-3.9)
14-year revision (%)	17,194	4.5 (4.4-4.6)	5.1 (5.0-5.2)
Minor revision³
1-year revision (%)	380,459	0.6 (0.5-0.6)	0.6 (0.6-0.6)
3-year revision (%)	312,992	0.7 (0.7-0.7)	0.8 (0.7-0.8)
5-year revision (%)	240,760	0.8 (0.7-0.8)	0.8 (0.8-0.9)
10-year revision (%)	95,353	0.9 (0.9-0.9)	1.0 (1.0-1.0)
14-year revision (%)	18,353	1.0 (0.9-1.0)	1.1 (1.1-1.2)

¹ The cumulative revision percentage using the Kaplan Meier method is shown in the figure.
² First revision of the acetabulum or femur component, regardless of whether a minor revision has already taken place. Therefor, the first three revision procedures were reviewed.
³ Only inlay and/or femoral head exchange (including DAIR procedures).
Please note: Dotted lines represent the upper and lower limits of the 95% confidence interval.
THA: total hip arthroplasty; CI: confidence interval.

In 2007-2022, 62,257 (15.3%) primary THAs were implanted in patients who died within fourteen years after the primary diagnosis

Hip » Survival » Revision by procedure characteristics » THA by procedure year

FIGURE Cumulative major revision percentage of total hip arthroplasties for osteoarthritis by procedure year of primary THA in the Netherlands in 2009-2022 (n=283,342)

TABLE Cumulative major revision percentages

		Cumulative major revision percentages – Kaplan Meier (95% CI)
Procedure year primary THA for osteoarthritis	Number (n)	1yr	3yr	5yr	7yr	10yr	13yr
2009-2010	38,309	0.94 (0.85-1.04)	1.98 (1.84-2.12)	2.71 (2.55-2.87)	3.31 (3.13-3.49)	4.31 (4.10-4.52)	5.16 (4.92-5.40)
2011-2012	42,811	0.93 (0.83-1.02)	1.85 (1.72-1.98)	2.36 (2.21-2.51)	2.84 (2.68-3.00)	3.58 (3.40-3.76)	n.a.
2013-2014	46,740	1.05 (0.96-1.14)	1.93 (1.80-2.06)	2.46 (2.32-2.60)	2.88 (2.73-3.03)	3.46 (3.27-3.65)	n.a.
2015-2016	50,268	1.00 (0.91-1.09)	1.79 (1.67-1.91)	2.28 (2.15-2.41)	2.66 (2.52-2.80)	n.a.	n.a.
2017-2018	53,690	1.08 (0.99-1.17)	1.76 (1.65-1.87)	2.18 (2.05-2.31)	n.a.	n.a.	n.a.
2019-2020	51,524	0.95 (0.87-1.04)	1.59 (1.48-1.70)	n.a.	n.a.	n.a.	n.a.

Major revision precentage: first revision of the acetabulum or femur component, regardless of whether a minor revision has already taken place. Therefor, the first three revision procedures were reviewed.
THA: total hip arthroplasty; CI: confidence interval; n.a. if <50 cases were at risk.

Hip » Survival » Revision by procedure characteristics » THA cemented by procedure year

FIGURE Cumulative major revision percentage of cemented total hip arthroplasties for osteoarthritis by procedure year of primary arthroplasty in the Netherlands in 2009-2022 (n=71,728)

TABLE Cumulative major revision percentages

		Cumulative major revision percentages – Kaplan Meier (95% CI)
Procedure year primary uncemented THA	Number (n)	1yr	3yr	5yr	7yr	10yr
2009-2010	23,429	1.12 (0.98-1.26)	2.33 (2.14-2.52)	3.27 (3.04-3.50)	3.99 (3.74-4.24)	4.97 (4.68-5.26)
2011-2012	27,054	1.07 (0.95-1.19)	2.07 (1.90-2.24)	2.59 (2.40-2.78)	3.08 (2.87-3.29)	3.83 (3.59-4.07)
2013-2014	29,399	1.15 (1.03-1.27)	2.05 (1.89-2.21)	2.54 (2.36-2.72)	2.95 (2.75-3.15)	3.45 (3.22-3.68)
2015-2016	32,682	1.12 (1.01-1.23)	1.87 (1.72-2.02)	2.33 (2.17-2.49)	2.69 (2.51-2.87)	n.a.
2017-2018	36,209	1.17 (1.06-1.28)	1.81 (1.67-1.95)	2.19 (2.04-2.34)	n.a.	n.a.
2019-2020	36,389	1.03 (0.93-1.13)	1.63 (1.50-1.76)	n.a.	n.a.	n.a.

Hip » Survival » Revision by procedure characteristics » THA uncemented by procedure year

FIGURE Cumulative major revision percentage of uncemented total hip arthroplasties for osteoarthritis by procedure year of primary arthroplasty in the Netherlands in 2009-2022 (n=185,162)

TABLE Cumulative major revision percentages

		Cumulative major revision percentages – Kaplan Meier (95% CI)
Procedure year primary uncemented THA	Number (n)	1yr	3yr	5yr	7yr	10yr
2009-2010	23,429	1.12 (0.98-1.26)	2.33 (2.14-2.52)	3.27 (3.04-3.50)	3.99 (3.74-4.24)	4.97 (4.68-5.26)
2011-2012	27,054	1.07 (0.95-1.19)	2.07 (1.90-2.24)	2.59 (2.40-2.78)	3.08 (2.87-3.29)	3.83 (3.59-4.07)
2013-2014	29,399	1.15 (1.03-1.27)	2.05 (1.89-2.21)	2.54 (2.36-2.72)	2.95 (2.75-3.15)	3.45 (3.22-3.68)
2015-2016	32,682	1.12 (1.01-1.23)	1.87 (1.72-2.02)	2.33 (2.17-2.49)	2.69 (2.51-2.87)	n.a.
2017-2018	36,209	1.17 (1.06-1.28)	1.81 (1.67-1.95)	2.19 (2.04-2.34)	n.a.	n.a.
2019-2020	36,389	1.03 (0.93-1.13)	1.63 (1.50-1.76)	n.a.	n.a.	n.a.

Hip » Survival » Revision by procedure characteristics » THA anterior approach by procedure year

FIGURE Cumulative major revision percentage of the anterior approach for total hip arthroplasties for osteoarthritis by procedure year of primary arthroplasty in the Netherlands in 2009-2022 (n=58,787)

TABLE Cumulative major revision percentages

		Cumulative major revision percentages – Kaplan Meier (95% CI)
Procedure year primary THA by anterior	Number (n)	1yr	3yr	5yr	7yr	10yr
2009-2010	1,556	1.03 (0.53-1.53)	3.24 (2.36-4.12)	4.03 (3.05-5.01)	4.72 (3.66-5.78)	5.16 (4.04-6.28)
2011-2012	2,810	0.89 (0.54-1.24)	1.79 (1.30-2.28)	2.02 (1.50-2.54)	2.40 (1.83-2.97)	2.89 (2.26-3.52)
2013-2014	5,589	0.86 (0.62-1.10)	1.62 (1.29-1.95)	1.96 (1.59-2.33)	2.19 (1.80-2.58)	2.99 (2.42-3.56)
2015-2016	10,172	0.69 (0.53-0.85)	1.25 (1.03-1.47)	1.47 (1.23-1.71)	1.61 (1.36-1.86)	n.a.
2017-2018	17,188	0.85 (0.71-0.99)	1.35 (1.18-1.52)	1.71 (1.51-1.91)	n.a.	n.a.
2019-2020	21,472	0.67 (0.56-0.78)	1.11 (0.97-1.25)	n.a.	n.a.	n.a.

Hip » Survival » Revision by procedure characteristics » THA posterior approach by procedure year

FIGURE Cumulative major revision percentage of the posterior approach for total hip arthroplasties for osteoarthritis by procedure year of primary arthroplasty in the Netherlands in 2009-2022 (n=161,584)

TABLE Cumulative major revision percentages

		Cumulative major revision percentages – Kaplan Meier (95% CI)
Procedure year primary THA by posterolateral	Number (n)	1yr	3yr	5yr	7yr	10yr
2009-2010	22,427	0.98 (0.85-1.11)	2.05 (1.86-2.24)	2.92 (2.70-3.14)	3.56 (3.31-3.81)	4.68 (4.39-4.97)
2011-2012	26,414	0.95 (0.83-1.06)	1.85 (1.69-2.01)	2.42 (2.23-2.61)	2.91 (2.70-3.12)	3.68 (3.44-3.92)
2013-2014	28,669	1.10 (0.98-1.22)	2.02 (1.86-2.18)	2.57 (2.38-2.76)	3.06 (2.86-3.26)	3.70 (3.45-3.95)
2015-2016	29,718	1.11 (0.99-1.23)	1.95 (1.79-2.11)	2.52 (2.34-2.70)	2.99 (2.79-3.19)	n.a.
2017-2018	28,916	1.22 (1.09-1.35)	1.96 (1.80-2.12)	2.43 (2.25-2.61)	n.a.	n.a.
2019-2020	25,440	1.19 (1.06-1.32)	1.96 (1.78-2.14)	n.a.	n.a.	n.a.

Hip » Survival » Revision by procedure characteristics » THA by procedure side

FIGURE Cumulative major revision percentage of total hip arthroplasties for osteoarthritis by procedure side in the Netherlands in 2007-2022 (n=362,270)

TABLE Cumulative major revision percentages

		Cumulative major revision percentages – Kaplan Meier (95% CI)
	Number (n)	1yr	3yr	5yr	7yr	10yr	14yr
Procedure side
Left	165,298	1.0 (0.9-1.0)	1.8 (1.7-1.9)	2.3 (2.3-2.4)	2.8 (2.7-2.9)	3.7 (3.6-3.8)	4.9 (4.7-5.0)
Right	196,972	1.0 (0.9-1.0)	1.8 (1.7-1.9)	2.4 (2.3-2.4)	2.9 (2.8-2.9)	3.6 (3.5-3.7)	4.8 (4.6-5.0)

Please note: Dotted lines represent the upper and lower limits of the 95% confidence interval.
THA: total hip arthroplasty; CI: confidence interval.

Hip » Survival » Revision by procedure characteristics » THA by approach

FIGURE Cumulative major revision percentage of total hip arthroplasties for osteoarthritis by approach in the Netherlands in 2007-2022 (n=358,792)

TABLE Cumulative major revision percentages

		Cumulative major revision percentages – Kaplan Meier (95% CI)
	Number (n)	1yr	3yr	5yr	7yr	10yr	14yr
Approach
Posterolateral	199,255	1.1 (1.0-1.1)	1.9 (1.9-2.0)	2.6 (2.5-2.6)	3.1 (3.0-3.2)	3.9 (3.8-4.0)	5.2 (5.0-5.4)
Anterior	86,528	0.7 (0.7-0.8)	1.3 (1.2-1.4)	1.7 (1.6-1.8)	2.0 (1.8-2.1)	2.6 (2.3-2.8)	3.6 (3.0-4.1)
Straight lateral	50,193	0.9 (0.8-1.0)	1.8 (1.7-1.9)	2.3 (2.2-2.5)	2.8 (2.7-3.0)	3.5 (3.3-3.7)	4.6 (4.3-4.9)
Anterolateal	19,989	1.0 (0.8-1.1)	2.0 (1.8-2.2)	2.6 (2.4-2.8)	3.0 (2.8-3.3)	3.9 (3.6-4.3)	5.2 (4.7-5.6)
Direct superior	2,827	0.8 (0.5-1.2)	1.2 (0.7-1.7)	1.7 (0.8-2.6)	n.a.	n.a.	n.a.

Please note: Dotted lines represent the upper and lower limits of the 95% confidence interval.
THA: total hip arthroplasty; CI: confidence interval; n.a. if <50 cases were at risk.

Hip » Survival » Revision by procedure characteristics » THA by femoral head size

FIGURE Cumulative revision percentage for dislocation of total hip arthroplasties for osteoarthritis by femoral head size in the Netherlands in 2007-2022 (n=349,595)

TABLE Cumulative revision percentages for dislocation

		Cumulative revision percentages for dislocation – Kaplan Meier (95% CI)
	Number (n)	1yr	3yr	5yr	7yr	10yr	14yr
Femoral head size
22-28 mm	83,450	0.6 (0.5-0.6)	0.9 (0.8-0.9)	1.1 (1.0-1.2)	1.3 (1.2-1.3)	1.5 (1.4-1.6)	1.8 (1.7-2.0)
32 mm	192,130	0.4 (0.4-0.4)	0.6 (0.6-0.6)	0.7 (0.7-0.8)	0.8 (0.8-0.9)	1.0 (0.9-1.0)	1.1 (1.0-1.2)
36 mm	74,015	0.3 (0.3-0.3)	0.5 (0.4-0.5)	0.5 (0.5-0.6)	0.6 (0.5-0.7)	0.7 (0.6-0.8)	0.9 (0.7-1.1)

Please note: Dotted lines represent the upper and lower limits of the 95% confidence interval.
THA: total hip arthroplasty; CI: confidence interval.

Hip » Survival » Revision by procedure characteristics » THA by articulation

FIGURE Cumulative major revision percentages of total hip arthroplasties for osteoarthritis by articulation in the Netherlands in 2007-2022 (n=345,444)

TABLE Cumulative major revision percentages

		Cumulative major revision percentages – Kaplan Meier (95% CI)
	Number (n)	1yr	3yr	5yr	7yr	10yr	14yr
Articulation
CoP	200,902	1.0 (0.9-1.0)	1.8 (1.7-1.8)	2.2 (2.2-2.3)	2.6 (2.6-2.7)	3.3 (3.2-3.4)	4.3 (4.1-4.5)
MoP	90,321	0.9 (0.9-1.0)	1.7 (1.6-1.8)	2.3 (2.2-2.4)	2.8 (2.7-2.9)	3.7 (3.5-3.8)	4.9 (4.6-5.1)
ZoP	25,457	0.9 (0.8-1.1)	1.7 (1.5-1.9)	2.2 (2.0-2.4)	2.7 (2.4-2.9)	3.2 (2.9-3.5)	3.7 (3.3-4.1)
CoC	23,506	0.8 (0.7-0.9)	1.5 (1.4-1.7)	1.9 (1.7-2.1)	2.2 (2.0-2.5)	2.9 (2.7-3.2)	4.0 (3.5-4.4)
MoM	5,258	1.5 (1.2-1.8)	4.5 (3.9-5.0)	7.9 (7.2-8.7)	10.1 (9.3-11.0)	12.5 (11.6-13.4)	14.9 (13.8-15.9)

Hip » Survival » Revision by procedure characteristics » THA by PE type

FIGURE Cumulative major revision percentages of total hip arthroplasties for osteoarthritis by inlay material in the Netherlands in 2007-2022 (n=362,608)

TABLE Cumulative major revision percentages

		Cumulative major revision percentages – Kaplan Meier (95% CI)
	Number (n)	1yr	3yr	5yr	7yr	10yr	14yr
Inlay material
XLPE	185,201	1.1 (1.0-1.1)	1.8 (1.7-1.8)	2.2 (2.2-2.3)	2.6 (2.6-2.7)	3.2 (3.1-3.4)	4.1 (3.8-4.3)
Non XLPE	177,407	0.9 (0.9-0.9)	1.8 (1.7-1.9)	2.4 (2.4-2.5)	3.0 (2.9-3.1)	3.9 (3.8-4.0)	5.2 (5.0-5.4)

Please note: Dotted lines represent the upper and lower limits of the 95% confidence interval.
Major revision precentage: first revision of the acetabulum or femur component, regardless of whether a minor revision has already taken place. Therefor, the first three revision procedures were reviewed.
CoP: Ceramics-on-polyethylene; MoP: Metal-on-polyethylene; ZoP: Oxidized Zirconium-on-polyethylene; CoC: Ceramics-on-ceramics; MoM: Metal-on-Metal; CoM: Ceramics-on-Metal
THA: total hip arthroplasty; CI: confidence interval; n.a. if <50 cases were at risk.

Hip » Survival » Revision by procedure characteristics » THA by modularity

FIGURE Cumulative femur revision percentage of total hip arthroplasties for osteoarthritis by femur modularity in the Netherlands in 2007-2022 (n=352,831)

TABLE Cumulative femur revision percentages

		Cumulative femur revision percentages – Kaplan Meier (95% CI)
	Number (n)	1yr	3yr	5yr	7yr	10yr	14yr
Modularity
Modular head	351,400	0.7 (0.6-0.7)	1.1 (1.1-1.2)	1.4 (1.4-1.5)	1.7 (1.6-1.7)	2.2 (2.1-2.2)	2.8 (2.7-2.9)
Modular neck	1,431	1.0 (0.5-1.5)	2.6 (1.8-3.4)	5.0 (3.9-6.2)	7.8 (6.3-9.2)	8.7 (7.2-10.2)	10.3 (8.4-12.2)

Femur revision percentage: first revision of the femur component, regardless of whether a minor revision has already taken place. Therefor, the first three revision procedures were reviewed.
Please note: Dotted lines represent the upper and lower limits of the 95% confidence interval.
THA: total hip arthroplasty; CI: confidence interval.

Hip » Survival » Revision by procedure characteristics » THA by ODEP 5A or higher acetabulum

FIGURE Cumulative acetabulum revision percentage of total hip arthroplasties for osteoarthritis by ODEP rating acetabulum in the Netherlands in 2007-2022 (n= 356,071)

TABLE Cumulative acetabulum revision percentages

		Cumulative acetabulum revision percentages – Kaplan Meier (95% CI)
	Number (n)	1yr	3yr	5yr	7yr	10yr	14yr
ODEP acetabulum
<5A	16,432	0.7 (0.6-0.8)	2.0 (1.8-2.2)	3.4 (3.1-3.6)	4.4 (4.0-4.7)	5.6 (5.2-6.0)	7.0 (6.5-7.5)
5A or higher	339,639	0.5 (0.5-0.5)	1.1 (1.1-1.1)	1.5 (1.4-1.5)	1.7 (1.7-1.8)	2.2 (2.1-2.3)	2.9 (2.8-3.0)

Acetabulum revision percentage: first revision of the acetabulum component, regardless of whether a minor revision has already taken place. Therefor, the first three revision procedures were reviewed.
ODEP rating: ODEP provides ratings for hip femoral stems, hip acetabular cups and total knee replacement implants. Detailed information can be found at www.odep.org.uk.
Please note: Dotted lines represent the upper and lower limits of the 95% confidence interval.
THA: total hip arthroplasty; CI: confidence interval.

Hip » Survival » Revision by procedure characteristics » THA by ODEP 5A or higher femur

FIGURE Cumulative femur revision percentage of total hip arthroplasties for osteoarthritis by ODEP rating femur in the Netherlands in 2007-2022 (n= 353,885)

TABLE Cumulative femur revision percentage

		Cumulative femur revision percentages – Kaplan Meier (95% CI)
	Number (n)	1yr	3yr	5yr	7yr	10yr	14yr
ODEP femur
<5A	13,730	1.2 (1.0-1.4)	2.0 (1.8-2.2)	2.5 (2.2-2.7)	3.0 (2.7-3.3)	3.8 (3.5-4.1)	4.9 (4.4-5.3)
5A or higher	340,155	0.6 (0.6-0.7)	1.1 (1.1-1.1)	1.4 (1.3-1.4)	1.7 (1.6-1.7)	2.1 (2.0-2.2)	2.7 (2.6-2.8)

Femur revision percentage: first revision of the femur component, regardless of whether a minor revision has already taken place. Therefor, the first three revision procedures were reviewed.
ODEP rating: ODEP provides ratings for hip femoral stems, hip acetabular cups and total knee replacement implants. Detailed information can be found at www.odep.org.uk.
Please note: Dotted lines represent the upper and lower limits of the 95% confidence interval.
THA: total hip arthroplasty; CI: confidence interval.

Hip » Survival » Revision by procedure characteristics » THA by cemented material acetabulum

FIGURE Cumulative acetabulum revision percentage of total hip arthroplasties for osteoarthritis by cemented acetabulum material in the Netherlands in 2007-2022 (n=94,072)

TABLE Cumulative acetabulum revision percentages

		Cumulative acetabulum revision percentages – Kaplan Meier (95% CI)
	Number (n)	1yr	3yr	5yr	7yr	10yr	14yr
Cemented acetabulum material
Standard PE	61,878	0.7 (0.6-0.7)	1.4 (1.3-1.5)	1.9 (1.8-2.0)	2.3 (2.2-2.4)	3.1 (2.9-3.3)	4.3 (4.0-4.5)
Cross-linked PE	29,906	0.4 (0.4-0.5)	1.0 (0.9-1.1)	1.4 (1.2-1.5)	1.6 (1.4-1.8)	1.9 (1.7-2.1)	2.1 (1.8-2.4)
Cross-linked PE + Antioxidant	2,288	0.4 (0.2-0.7)	1.1 (0.7-1.6)	1.6 (1.0-2.2)	2.3 (1.4-3.2)	2.3 (1.4-3.2)	n.a.

Acetabulum revision percentage: first revision of the acetabulum component, regardless of whether a minor revision has already taken place. Therefor, the first three revision procedures were reviewed.
Please note: Dotted lines represent the upper and lower limits of the 95% confidence interval.
THA: total hip arthroplasty; PE: polyethylene; CI: confidence interval; n.a. if <50 cases were at risk.

Hip » Survival » Revision by procedure characteristics » THA by cemented material femur

FIGURE Cumulative femur revision percentage of total hip arthroplasties for osteoarthritis by cemented femur material in the Netherlands in 2007-2022 (n=260,625)

TABLE Cumulative femur revision percentages

		Cumulative femur revision percentages – Kaplan Meier (95% CI)
	Number (n)	1yr	3yr	5yr	7yr	10yr	14yr
Cemented femur material
Cobalt chrome	16,152	0.3 (0.2-0.4)	0.7 (0.6-0.8)	1.2 (1.0-1.4)	1.5 (1.3-1.7)	1.8 (1.5-2.1)	2.3 (1.8-2.7)
Stainless steel	4,113	0.5 (0.3-0.7)	0.8 (0.5-1.1)	0.8 (0.5-1.2)	1.1 (0.7-1.5)	1.5 (0.9-2.1)	1.9 (0.9-3.0)
Titanium	360	1.4 (0.2-2.7)	2.1 (0.6-3.6)	2.1 (0.6-3.6)	3.4 (1.3-5.6)	3.4 (1.3-5.6)	n.a.

Femur revision percentage: first revision of the femur component, regardless of whether a minor revision has already taken place. Therefor, the first three revision procedures were reviewed.
Please note: Dotted lines represent the upper and lower limits of the 95% confidence interval.
THA: total hip arthroplasty; CI: confidence interval.

Hip » Survival » Revision by procedure characteristics » THA by uncemented material femur

FIGURE Cumulative femur revision percentage of total hip arthroplasties for osteoarthritis by uncemented femur material in the Netherlands in 2007-2021 (n=18,297)

TABLE Cumulative femur revision percentages

		Cumulative femur revision percentages – Kaplan Meier (95% CI)
	Number (n)	1yr	3yr	5yr	7yr	10yr	14yr
Cemented femur material
Cobalt chrome	16,152	0.3 (0.2-0.4)	0.7 (0.6-0.8)	1.2 (1.0-1.4)	1.5 (1.3-1.7)	1.8 (1.5-2.1)	2.3 (1.8-2.7)
Stainless steel	4,113	0.5 (0.3-0.7)	0.8 (0.5-1.1)	0.8 (0.5-1.2)	1.1 (0.7-1.5)	1.5 (0.9-2.1)	1.9 (0.9-3.0)
Titanium	360	1.4 (0.2-2.7)	2.1 (0.6-3.6)	2.1 (0.6-3.6)	3.4 (1.3-5.6)	3.4 (1.3-5.6)	n.a.

Femur revision percentage: first revision of the femur component, regardless of whether a minor revision has already taken place. Therefor, the first three revision procedures were reviewed.
Please note: Dotted lines represent the upper and lower limits of the 95% confidence interval.
THA: total hip arthroplasty; CI: confidence interval.

Hip » Survival » Revision by procedure characteristics » THA by uncemented material inlay

FIGURE Cumulative acetabulum revision percentage of total hip arthroplasties for osteoarthritis by uncemented inlay material in the Netherlands in 2007-2022 (n=229,639)

TABLE Cumulative acetabulum revision percentages

		Cumulative acetabulum revision percentages – Kaplan Meier (95% CI)
	Number (n)	1yr	3yr	5yr	7yr	10yr	14yr
Uncemented inlay material
Cross-linked PE	161,064	0.5 (0.4-0.5)	1.0 (0.9-1.0)	1.3 (1.2-1.4)	1.5 (1.4-1.6)	1.8 (1.7-1.9)	2.2 (2.0-2.3)
Standard PE	22,825	0.5 (0.4-0.6)	1.0 (0.9-1.2)	1.5 (1.3-1.6)	1.8 (1.7-2.0)	2.4 (2.2-2.6)	2.9 (2.7-3.2)
Ceramics/Oxidized Zirconium	21,639	0.4 (0.3-0.5)	0.9 (0.8-1.1)	1.2 (1.0-1.3)	1.3 (1.2-1.5)	1.7 (1.5-1.9)	2.0 (1.7-2.4)
Cross-linked PE + Antioxidant	19,413	0.6 (0.5-0.7)	1.1 (0.9-1.2)	1.3 (1.1-1.5)	1.6 (1.4-1.8)	1.9 (1.7-2.2)	n.a.
Cobalt chrome	3,476	0.8 (0.5-1.1)	1.7 (1.3-2.2)	2.5 (2.0-3.1)	3.2 (2.6-3.8)	4.4 (3.7-5.2)	5.6 (4.7-6.4)
Ceramics	1,222	0.8 (0.3-1.2)	1.5 (0.8-2.1)	1.7 (1.0-2.5)	2.1 (1.3-2.9)	2.8 (1.8-3.7)	3.8 (2.6-4.9)

Acetabulum revision percentage: first revision of the acetabulum component, regardless of whether a minor revision has already taken place. Therefor, the first three revision procedures were reviewed.
Please note: Dotted lines represent the upper and lower limits of the 95% confidence interval.
THA: total hip arthroplasty; PE: polyethylene; CI: confidence interval; n.a. if <50 cases were at risk.

This website is only accessable on large screens